Serotonin Receptors and SSRIs
Doctor Jon Lieberman discusses the propsed mechanism of Selective Serotonin Reuptake Inhibitors (SSRIs), a controversial treatment for depression.
Depressed people have low serotonin levels. What SSRIs (Selective Serotonin Reuptake Inhibitors) do, is keep serotonin at the synapses of the brain.
depression, treatment, serotonin, receptor, selective, serotonin, reuptake, inhibitors, SSRI, SSRIs, jon, lieberman,
Professor Wayne Drevets discusses the serotonin system in relation to depression. Drugs that block serotonin reuptake in the brain (SSRIs) are commonly used to treat depression.
Professor Wayne Drevets examines the efficacy of selective serotonin reuptake inhibitors (SSRIs) in treating depression. Not all patients respond well to SSRIs and may need different treatments.
An overview of depression-related content on Genes to Cognition Online.
Professor James Potash discusses recent findings that question the effectiveness of serotonin reuptake inhibitors (SSRIs).
Serotonin is the biochemical most commonly associated with depression. Professor Wayne Drevets discusses other systems including norepinephrine, glutamate, and dopamine.
The 5-HTT gene has been associated with both depression and autism.
Doctor Jon Lieberman discusses three neurotransmitters that have been associated with depression - dopamine, serotonin, and norepinephrine.
A review of antidepressant medications.
"Over time, the aggregate risk of completed suicide is likely to be much lower with treatment than without treatment," says Steve Hyman, former director of the National Institute of Mental Health.
Many researchers are finding new ways to use drugs already available for treating depression.